1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
4 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2020 | |
|---|---|---|
| Revenue | 2.98M | 52.19% |
| Gross profit | 2.98M | 52.19% |
| Net profit | -28.74M | 19.45% |
| EBITDA | -26.59M | 25.97% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €0 |
52-week high/low | €6.10 - €6.02 |
| Dividends | No |
Beta | 0.80 |
P/E ratio | -8.91 |
PEG ratio | -0.27 |
P/B ratio | 20.01 |
P/S ratio | 0.00 |
Company profile
| Name | TAIWAN LIPOSOME SP.ADR/2 |
| CEO | Keelung Hong |
| Headquarters | Taipei,
Taiwan |
| Website | |
| Sector | Materials |
| Industry | Chemicals |
| IPO | 11/21/2018 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | TLC |
Discover assets
Shareholders of TAIWAN LIPOSOME SP.ADR/2 also invest in the following assets
